New Delhi, Apr 10 (PTI) Drug maker Lupin on Wednesday said it has launched the generic version of Oracea capsules in the US market.

The company said it has launched the medication, indicated for the treatment of inflammatory lesions (papules and pustules) of rosacea, following approval from the US Food and Drug Administration (USFDA).

Also Read | BJP Foundation Day 2024 Date: Know the History and Significance of BJP Sthapna Diwas That Celebrates the Formation of the Bharatiya Janata Party.

As per the IQVIA MAT data, Doxycycline capsules (Oracea) had estimated annual sales of USD 128 million in the US.

Shares of the company were trading 0.77 per cent up at Rs 1,617.35 apiece on the BSE.

Also Read | AMC Raising Day 2024: Army Medical Corps Celebrates 260th Raising Day as They Live Up To The Corps Motto.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)